FINANCIALS

NTLA Intellia Therapeutics Inc 1652130

Income Statement
Revenue	ntla-20241231	57,877,000
Net Income	ntla-20241231	-519,021,000
Profit Margin		-896.77%

Balance Sheet
Current Assets	639,863,000
Assets	1,191,015,000
Current Liabilities	110,851,000
Liabilities	319,059,000
Equity	871,956,000
Shares Out	101,579,000

Cash Flow Statement
Operating Cash Flow	-348,880,000
Investing Cash Flow	125,567,000

Market Analysis
Market Cap	2,296,705,773
Price	8.98
BVPS	8.58
PB	1.07
EPS	-5.48
PS	9.92
FCF	-223,313,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view NTLA documents filed with the SEC.

NTLA Filings Clear

View A List of Tickers